Work

Proposal for a Dedicated ICD-10-CM Diagnostic Code for Fluoroquinolone-Associated Disability (FQAD)

Year: 2026
Type: report
Abstract: This document is a formal proposal submitted to the National Center for Health Statistics (NCHS) requesting the creation of a dedicated ICD-10-CM diagnostic code for Fluoroquinolone-Associated Disability (FQAD). The proposal addresses the absence of a distinct diagnostic classification for patients experiencing disabling, multisystem adverse effects following fluoroquinolone exposure, including delayed onset, persistent symptoms, and progression after discontinuation. Existing fluoroquinolone-specific adverse-effect codes identify the implicated drug but do not independently identify FQAD as a clinical condition. The proposed diagnostic classification is intended to support clinical recognition, standardized documentation, patient identification, epidemiological research, and longitudinal surveillance necessary to establish incidence and prevalence. Document status: Formally submitted for consideration. Not an approved ICD-10-CM code. Author: Johanna Ihli, BSN, Former Registered Nurse | Independent Researcher.
Language: English
Subfield: Toxicology
Open Access status: green
OpenAlex ID: W7225695556
Cites:
Cited by:
Related to: 10